Posted in | News | Display

NextWindow Awarded Two Key Technology Patents

NextWindow, the leader in optical touch screens for all-in-one PCs and large-format displays, has been awarded two key technology patents, one in the US and another in China. The newly granted patents which refer to optical touch systems incorporating light emitters, reflectors and detection methods, help cement NextWindow's leadership positions in the important Chinese manufacturing and US sales markets.

The US patent, number 7,538,759, issued by the United States Patent & Trademark Office on May 26, 2009, is titled, "Touch Panel Display System with Illumination and Detection Provided from a Single Edge." NextWindow previously was granted this patent in Australia, and a request for patent is pending in Canada, Europe, Hong Kong and Japan.

The Chinese patent, number 200480009926, issued by the State Intellectual Property Office of the P.R.C. on March 11, 2009, is titled, "Touch Panel and Method of Optically Detecting the Presence of an Object in relation to the Touch Screen." A request for this patent also has been filed in Australia, the US, Europe, Japan and Korea.

"NextWindow has invested significant research and development resources in the optical touch screen space, and these patents represent the latest additions to our growing IP portfolio extending around the world," said Al Monro, CEO at NextWindow. "That the patents were granted in critical international markets where a number of our customers and partners are based also is significant, given the importance of gaining competitive advantage at this very dynamic time in the rapidly growing touch screen market. Likewise, the new patents demonstrate NextWindow's ongoing commitment to innovation, dating back nearly 10 years."

NextWindow has been growing its patent portfolio since 2000. The company previously was granted patents for its optical touch screen technology in the US and Australia, and several other patents relating to its optical touch screen technology are pending throughout the world.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.